0001415889-24-004231.txt : 20240216
0001415889-24-004231.hdr.sgml : 20240216
20240216182100
ACCESSION NUMBER: 0001415889-24-004231
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GARCIA PETER S
CENTRAL INDEX KEY: 0001188956
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 24649973
MAIL ADDRESS:
STREET 1: ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-02162024_110247.xml
X0508
4
2024-02-14
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001188956
GARCIA PETER S
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Common Stock
2024-02-14
4
A
0
25000
0
A
110348
D
Employee Stock Option (right to buy)
15.84
2024-02-14
4
A
0
80000
0
A
2034-02-13
Common Stock
80000
80000
D
The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.
/s/ Peter Garcia
2024-02-16